Funding awarded
- Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies awarded by National Cancer Institute Key Personnel 2025 - 2030
- Engineered IgA engagers to fight cancer awarded by Advanced Research Projects Agency for Health Key Personnel 2025 - 2027